ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
investment factor · long-only model fund

Foundry Investment Discipline Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FINVHYPOTHETICAL MODEL
Since ’99
+493%
Expense Ratio
0.29%
placeholder
Holdings
262
cap-weighted
Inception
May 2020
placeholder
Full Sharpe
0.54
Ann. Return (LS)
7.4%
Ann. Volatility
13.8%
Max Drawdown
-39.3%
Test Sharpe ’19–26
0.14
Test FF5 α (ann.)
2.9%
vs Fama-French 5
Test FF5 α t-stat
0.56
not significant
Monthly turnover
18%
of the long leg, per rebalance
Cumulative return (LS)
493%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.60
what this fund holds
Long leg ann. return
12.0%
buyable, long-only
Long-short Sharpe
0.54
requires shorting
Bottom bucket ann. return
4.6%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

262 of 262 · 100.0% of book
TickerCompanySectorMarket capWeight
1APP
APPLOVIN CORPTechnology$142.62B
14.17%
2SRE
SEMPRAUtilities$60.30B
5.99%
3ONC
BEONE MEDICINES LTDHealthcare$34.68B
3.45%
4CCI
CROWN CASTLE INCReal Estate$34.55B
3.43%
5ON
ON SEMICONDUCTOR CORPTechnology$34.24B
3.40%
6STLD
STEEL DYNAMICS INCBasic Materials$33.96B
3.37%
7ZM
ZOOM COMMUNICATIONS INCTechnology$26.72B
2.65%
8EQR
EQUITY RESIDENTIALReal Estate$25.85B
2.57%
9MDB
MONGODB INCTechnology$25.12B
2.50%
10MRNA
MODERNA INCHealthcare$24.53B
2.44%
11SBAC
SBA COMMUNICATIONS CORPReal Estate$19.69B
1.96%
12DD
DUPONT DE NEMOURS INCBasic Materials$18.49B
1.84%
13BEN
FRANKLIN RESOURCES INCFinancial Services$16.96B
1.68%
14TLN
TALEN ENERGY CORPUtilities$16.90B
1.68%
15GEN
GEN DIGITAL INCTechnology$16.11B
1.60%
16ALB
ALBEMARLE CORPBasic Materials$14.24B
1.42%
17EXEL
EXELIXIS INCHealthcare$14.06B
1.40%
18EQH
EQUITABLE HOLDINGS INCFinancial Services$13.79B
1.37%
19AMH
AMERICAN HOMES 4 RENTReal Estate$12.29B
1.22%
20CPT
CAMDEN PROPERTY TRUSTReal Estate$11.36B
1.13%
21CGNX
COGNEX CORPTechnology$10.66B
1.06%
22ARWR
ARROWHEAD PHARMACEUTICALS INCHealthcare$10.47B
1.04%
23APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
1.00%
24SSB
SOUTHSTATE BANK CORPFinancial Services$10.08B
1.00%
25CORT
CORCEPT THERAPEUTICS INCHealthcare$9.72B
0.97%
26KYMR
KYMERA THERAPEUTICS INCHealthcare$9.52B
0.95%
27REXR
REXFORD INDUSTRIAL REALTY INCReal Estate$8.46B
0.84%
28IMVT
IMMUNOVANT INCHealthcare$8.27B
0.82%
29PCVX
VAXCYTE INCHealthcare$8.12B
0.81%
30DBX
DROPBOX INCTechnology$7.14B
0.71%
31LNTH
LANTHEUS HOLDINGS INCHealthcare$7.00B
0.70%
32XENE
XENON PHARMACEUTICALS INCHealthcare$6.60B
0.66%
33RYN
RAYONIER INCReal Estate$6.56B
0.65%
34PTCT
PTC THERAPEUTICS INCHealthcare$6.52B
0.65%
35GATX
GATX CORPIndustrials$6.34B
0.63%
36PATH
UIPATH INCTechnology$6.30B
0.63%
37RIG
TRANSOCEAN LTDEnergy$5.74B
0.57%
38QLYS
QUALYS INCTechnology$5.61B
0.56%
39LAZ
LAZARD INCFinancial Services$4.82B
0.48%
40SKT
TANGER INCReal Estate$4.80B
0.48%
41FULT
FULTON FINANCIAL CORPFinancial Services$4.74B
0.47%
42KRC
KILROY REALTY CORPReal Estate$4.68B
0.46%
43TCBI
TEXAS CAPITAL BANCSHARES INCFinancial Services$4.59B
0.46%
44LBRDA
LIBERTY BROADBAND CORPCommunication Services$4.43B
0.44%
45INSW
INTERNATIONAL SEAWAYS INCEnergy$4.29B
0.43%
46GPGI
GPGI INCIndustrials$4.21B
0.42%
47OPLN
OPENLANE INCConsumer Cyclical$4.18B
0.42%
48WSFS
WSFS FINANCIAL CORPFinancial Services$4.16B
0.41%
49LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.40%
50THO
THOR INDUSTRIES INCConsumer Cyclical$3.97B
0.39%
51WSBC
WESBANCO INCFinancial Services$3.92B
0.39%
52NHI
NATIONAL HEALTH INVESTORS INCReal Estate$3.86B
0.38%
53CPRX
CATALYST PHARMACEUTICALS INCHealthcare$3.85B
0.38%
54RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.38%
55DNLI
DENALI THERAPEUTICS INCHealthcare$3.70B
0.37%
56NIC
NICOLET BANKSHARES INCFinancial Services$3.61B
0.36%
57ARQT
ARCUTIS BIOTHERAPEUTICS INCHealthcare$3.56B
0.35%
58BKU
BANKUNITED INCFinancial Services$3.55B
0.35%
59CRGY
CRESCENT ENERGY COEnergy$3.55B
0.35%
60CALY
CALLAWAY GOLF COConsumer Cyclical$3.48B
0.35%
61RCUS
ARCUS BIOSCIENCES INCHealthcare$3.44B
0.34%
62CLSK
CLEANSPARK INCFinancial Services$3.34B
0.33%
63PPLI
PEOPLE INCCommunication Services$3.31B
0.33%
64SEDG
SOLAREDGE TECHNOLOGIES INCTechnology$3.25B
0.32%
65SAH
SONIC AUTOMOTIVE INCConsumer Cyclical$3.17B
0.32%
66CARG
CARGURUS INCConsumer Cyclical$3.16B
0.31%
67MMS
MAXIMUS INCIndustrials$3.06B
0.30%
68AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.30%
69AKR
ACADIA REALTY TRUSTReal Estate$3.00B
0.30%
70BELFA
BEL FUSE INCTechnology$2.91B
0.29%
71IRON
DISC MEDICINE INCHealthcare$2.91B
0.29%
72APAM
ARTISAN PARTNERS ASSET MANAGEMENT INCFinancial Services$2.73B
0.27%
73DJT
TRUMP MEDIA & TECHNOLOGY GROUP CORPCommunication Services$2.68B
0.27%
74KALU
KAISER ALUMINUM CORPBasic Materials$2.58B
0.26%
75QURE
UNIQURE NVHealthcare$2.54B
0.25%
76VCEL
VERICEL CORPHealthcare$2.38B
0.24%
77BHVN
BIOHAVEN LTDHealthcare$2.32B
0.23%
78NKTR
NEKTAR THERAPEUTICSHealthcare$2.31B
0.23%
79HTH
HILLTOP HOLDINGS INCFinancial Services$2.26B
0.22%
80PVLA
PALVELLA THERAPEUTICS INCHealthcare$2.26B
0.22%
81MLYS
MINERALYS THERAPEUTICS INCHealthcare$2.23B
0.22%
82AGM
FEDERAL AGRICULTURAL MORTGAGE CORPFinancial Services$2.23B
0.22%
83SHO
SUNSTONE HOTEL INVESTORS INCReal Estate$2.19B
0.22%
84PEB
PEBBLEBROOK HOTEL TRUSTReal Estate$2.16B
0.21%
85SGRY
SURGERY PARTNERS INCHealthcare$2.09B
0.21%
86RAPP
RAPPORT THERAPEUTICS INCHealthcare$2.04B
0.20%
87HRMY
HARMONY BIOSCIENCES HOLDINGS INCHealthcare$1.96B
0.19%
88TYRA
TYRA BIOSCIENCES INCHealthcare$1.91B
0.19%
89CCS
CENTURY COMMUNITIES INCConsumer Cyclical$1.89B
0.19%
90IIPR
INNOVATIVE INDUSTRIAL PROPERTIES INCReal Estate$1.86B
0.18%
91SRPT
SAREPTA THERAPEUTICS INCHealthcare$1.82B
0.18%
92SONO
SONOS INCTechnology$1.80B
0.18%
93GEL
GENESIS ENERGY LPEnergy$1.79B
0.18%
94NN
NEXTNAV INCTechnology$1.78B
0.18%
95DCOM
DIME COMMUNITY BANCSHARES INCFinancial Services$1.78B
0.18%
96AESI
ATLAS ENERGY SOLUTIONS INCEnergy$1.76B
0.17%
97ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.17%
98GLP
GLOBAL PARTNERS LPEnergy$1.63B
0.16%
99KRP
KIMBELL ROYALTY PARTNERS LPEnergy$1.61B
0.16%
100INVA
INNOVIVA INCHealthcare$1.60B
0.16%
101NTLA
INTELLIA THERAPEUTICS INCHealthcare$1.59B
0.16%
102GBX
GREENBRIER COMPANIES INCIndustrials$1.55B
0.15%
103CSWC
CAPITAL SOUTHWEST CORPFinancial Services$1.51B
0.15%
104WWW
WOLVERINE WORLD WIDE INCConsumer Cyclical$1.51B
0.15%
105MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.14%
106MRTN
MARTEN TRANSPORT LTDIndustrials$1.44B
0.14%
107ULCC
FRONTIER GROUP HOLDINGS INCIndustrials$1.43B
0.14%
108TWFG
TWFG INCFinancial Services$1.43B
0.14%
109VPG
VISHAY PRECISION GROUP INCTechnology$1.38B
0.14%
110STAA
STAAR SURGICAL COHealthcare$1.32B
0.13%
111DMLP
DORCHESTER MINERALS LPEnergy$1.31B
0.13%
112UFCS
UNITED FIRE GROUP INCFinancial Services$1.31B
0.13%
113XNCR
XENCOR INCHealthcare$1.30B
0.13%
114ABSI
ABSCI CORPHealthcare$1.29B
0.13%
115INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.13%
116LADR
LADDER CAPITAL CORPReal Estate$1.28B
0.13%
117IRMD
IRADIMED CORPHealthcare$1.24B
0.12%
118SAFE
SAFEHOLD INCReal Estate$1.22B
0.12%
119OSBC
OLD SECOND BANCORP INCFinancial Services$1.22B
0.12%
120HTLD
HEARTLAND EXPRESS INCIndustrials$1.19B
0.12%
121ORIC
ORIC PHARMACEUTICALS INCHealthcare$1.11B
0.11%
122CRAI
CRA INTERNATIONAL INCIndustrials$1.11B
0.11%
123CIM
CHIMERA INVESTMENT CORPReal Estate$1.08B
0.11%
124MCBS
METROCITY BANKSHARES INCFinancial Services$1.04B
0.10%
125UTZ
UTZ BRANDS INCConsumer Defensive$1.04B
0.10%
126CPF
CENTRAL PACIFIC FINANCIAL CORPFinancial Services$1.02B
0.10%
127CCNE
CNB FINANCIAL CORPFinancial Services$1.02B
0.10%
128OLMA
OLEMA PHARMACEUTICALS INCHealthcare$1.00B
0.10%
129VOR
VOR BIOPHARMA INCHealthcare$980M
0.10%
130ANRO
ALTO NEUROSCIENCE INCHealthcare$967M
0.10%
131LWLG
LIGHTWAVE LOGIC INCBasic Materials$960M
0.10%
132APEI
AMERICAN PUBLIC EDUCATION INCConsumer Defensive$930M
0.09%
133CAC
CAMDEN NATIONAL CORPFinancial Services$917M
0.09%
134TBPH
THERAVANCE BIOPHARMA INCHealthcare$873M
0.09%
135NPK
NATIONAL PRESTO INDUSTRIES INCIndustrials$870M
0.09%
136LMB
LIMBACH HOLDINGS INCIndustrials$867M
0.09%
137FMNB
FARMERS NATIONAL BANC CORPFinancial Services$867M
0.09%
138HPP
HUDSON PACIFIC PROPERTIES INCReal Estate$853M
0.08%
139HTB
HOMETRUST BANCSHARES INCFinancial Services$824M
0.08%
140ADAM
ADAMAS TRUST INCReal Estate$807M
0.08%
141FPH
FIVE POINT HOLDINGS LLCReal Estate$778M
0.08%
142REPX
RILEY EXPLORATION PERMIAN INCEnergy$759M
0.08%
143CTO
CTO REALTY GROWTH INCReal Estate$751M
0.07%
144RIGL
RIGEL PHARMACEUTICALS INCHealthcare$750M
0.07%
145AURA
AURA BIOSCIENCES INCHealthcare$723M
0.07%
146INN
SUMMIT HOTEL PROPERTIES INCReal Estate$722M
0.07%
147OMER
OMEROS CORPHealthcare$701M
0.07%
148MAMA
MAMA'S CREATIONS INCConsumer Defensive$700M
0.07%
149WASH
WASHINGTON TRUST BANCORP INCFinancial Services$698M
0.07%
150SPRY
ARS PHARMACEUTICALS INCHealthcare$695M
0.07%
151DGICA
DONEGAL GROUP INCFinancial Services$693M
0.07%
152TIPT
TIPTREE INCFinancial Services$669M
0.07%
153CWH
CAMPING WORLD HOLDINGS INCConsumer Cyclical$637M
0.06%
154NFBK
NORTHFIELD BANCORP INCFinancial Services$621M
0.06%
155FDMT
4D MOLECULAR THERAPEUTICS INCHealthcare$575M
0.06%
156ELA
ENVELA CORPConsumer Cyclical$547M
0.05%
157XMAX
XMAX INCConsumer Cyclical$541M
0.05%
158VSTM
VERASTEM INCHealthcare$530M
0.05%
159DNA
GINKGO BIOWORKS HOLDINGS INCHealthcare$517M
0.05%
160OIS
OIL STATES INTERNATIONAL INCEnergy$507M
0.05%
161XOMA
XOMA ROYALTY CORPHealthcare$504M
0.05%
162OBT
ORANGE COUNTY BANCORP INCFinancial Services$504M
0.05%
163CLMB
CLIMB GLOBAL SOLUTIONS INCTechnology$482M
0.05%
164AMCX
AMC GLOBAL MEDIA INCCommunication Services$461M
0.05%
165WTBA
WEST BANCORPORATION INCFinancial Services$460M
0.05%
166PANL
PANGAEA LOGISTICS SOLUTIONS LTDIndustrials$460M
0.05%
167PRTA
PROTHENA CORP PUBLIC LTD COHealthcare$453M
0.05%
168TITN
TITAN MACHINERY INCIndustrials$446M
0.04%
169SRTA
STRATA CRITICAL MEDICAL INCIndustrials$446M
0.04%
170NEWT
NEWTEKONE INCFinancial Services$439M
0.04%
171PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.04%
172ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.04%
173FPI
FARMLAND PARTNERS INCReal Estate$424M
0.04%
174CLFD
CLEARFIELD INCTechnology$416M
0.04%
175SMC
SUMMIT MIDSTREAM CORPEnergy$407M
0.04%
176ENTA
ENANTA PHARMACEUTICALS INCHealthcare$400M
0.04%
177TCI
TRANSCONTINENTAL REALTY INVESTORS INCReal Estate$394M
0.04%
178EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.04%
179FLXS
FLEXSTEEL INDUSTRIES INCConsumer Cyclical$391M
0.04%
180STRO
SUTRO BIOPHARMA INCHealthcare$391M
0.04%
181VALU
VALUE LINE INCFinancial Services$385M
0.04%
182LAND
GLADSTONE LAND CORPReal Estate$378M
0.04%
183CHMG
CHEMUNG FINANCIAL CORPFinancial Services$366M
0.04%
184SEG
SEAPORT ENTERTAINMENT GROUP INCReal Estate$332M
0.03%
185NODK
NI HOLDINGS INCFinancial Services$326M
0.03%
186FVCB
FVCBANKCORP INCFinancial Services$321M
0.03%
187JMSB
JOHN MARSHALL BANCORP INCFinancial Services$313M
0.03%
188PAMT
PAMT CORPIndustrials$311M
0.03%
189FHTX
FOGHORN THERAPEUTICS INCHealthcare$305M
0.03%
190PNRG
PRIMEENERGY RESOURCES CORPEnergy$302M
0.03%
191ASLE
AERSALE CORPIndustrials$286M
0.03%
192FRAF
FRANKLIN FINANCIAL SERVICES CORPFinancial Services$281M
0.03%
193LCNB
LCNB CORPFinancial Services$273M
0.03%
194TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.03%
195TBCH
TURTLE BEACH CORPTechnology$258M
0.03%
196ARL
AMERICAN REALTY INVESTORS INCReal Estate$257M
0.03%
197RILY
BRC GROUP HOLDINGS INCFinancial Services$254M
0.03%
198VABK
VIRGINIA NATIONAL BANKSHARES CORPFinancial Services$250M
0.02%
199ASYS
AMTECH SYSTEMS INCTechnology$242M
0.02%
200QUIK
QUICKLOGIC CORPTechnology$237M
0.02%
201EFSI
EAGLE FINANCIAL SERVICES INCFinancial Services$229M
0.02%
202ALOT
ASTRONOVA INCTechnology$222M
0.02%
203FOA
FINANCE OF AMERICA COMPANIES INCFinancial Services$216M
0.02%
204KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.02%
205SENS
SENSEONICS HOLDINGS INCHealthcare$214M
0.02%
206GSIT
GSI TECHNOLOGY INCTechnology$208M
0.02%
207IMUX
IMMUNIC INCHealthcare$207M
0.02%
208BDSX
BIODESIX INCHealthcare$204M
0.02%
209DTIL
PRECISION BIOSCIENCES INCHealthcare$203M
0.02%
210AMWL
AMERICAN WELL CORPHealthcare$199M
0.02%
211PAL
PROFICIENT AUTO LOGISTICS INCIndustrials$197M
0.02%
212LARK
LANDMARK BANCORP INCFinancial Services$190M
0.02%
213WHG
WESTWOOD HOLDINGS GROUP INCFinancial Services$188M
0.02%
214BVFL
BV FINANCIAL INCFinancial Services$186M
0.02%
215EBMT
EAGLE BANCORP MONTANA INCFinancial Services$185M
0.02%
216CBFV
CB FINANCIAL SERVICES INCFinancial Services$184M
0.02%
217PDEX
PRO DEX INCHealthcare$183M
0.02%
218OZ
BELPOINTE PREP LLCReal Estate$181M
0.02%
219INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.02%
220HNVR
HANOVER BANCORP INCFinancial Services$179M
0.02%
221KRRO
KORRO BIO INCHealthcare$177M
0.02%
222ARCT
ARCTURUS THERAPEUTICS HOLDINGS INCHealthcare$172M
0.02%
223HQI
HIREQUEST INCIndustrials$168M
0.02%
224EPSN
EPSILON ENERGY LTDEnergy$167M
0.02%
225STRS
STRATUS PROPERTIES INCReal Estate$165M
0.02%
226FGBI
FIRST GUARANTY BANCSHARES INCFinancial Services$164M
0.02%
227TRAK
REPOSITRAK INCTechnology$160M
0.02%
228FNWD
FINWARD BANCORPFinancial Services$157M
0.02%
229RCEL
AVITA MEDICAL INCHealthcare$157M
0.02%
230CHPT
CHARGEPOINT HOLDINGS INCConsumer Cyclical$146M
0.01%
231UNCY
UNICYCIVE THERAPEUTICS INCHealthcare$144M
0.01%
232SIF
SIFCO INDUSTRIES INCIndustrials$141M
0.01%
233OPRX
OPTIMIZERX CORPHealthcare$126M
0.01%
234GHI
GREYSTONE HOUSING IMPACT INVESTORS LPFinancial Services$123M
0.01%
235BOTJ
BANK OF THE JAMES FINANCIAL GROUP INCFinancial Services$121M
0.01%
236SFBC
SOUND FINANCIAL BANCORP INCFinancial Services$120M
0.01%
237BSBK
BOGOTA FINANCIAL CORPFinancial Services$116M
0.01%
238FNWB
FIRST NORTHWEST BANCORPFinancial Services$116M
0.01%
239TCX
TUCOWS INCTechnology$114M
0.01%
240MGYR
MAGYAR BANCORP INCFinancial Services$113M
0.01%
241TZOO
TRAVELZOOCommunication Services$113M
0.01%
242RVSB
RIVERVIEW BANCORP INCFinancial Services$107M
0.01%
243VRCA
VERRICA PHARMACEUTICALS INCHealthcare$96M
0.01%
244MHH
MASTECH DIGITAL INCIndustrials$89M
0.01%
245RPT
RITHM PROPERTY TRUST INCReal Estate$85M
0.01%
246CPBI
CENTRAL PLAINS BANCSHARES INCIndustrials$85M
0.01%
247INTG
INTERGROUP CORPConsumer Cyclical$84M
0.01%
248CPHC
CANTERBURY PARK HOLDING CORPConsumer Cyclical$82M
0.01%
249FSEA
FIRST SEACOAST BANCORP INCFinancial Services$79M
0.01%
250ACET
ADICET BIO INCHealthcare$76M
0.01%
251BNAI
BRAND ENGAGEMENT NETWORK INCTechnology$76M
0.01%
252AIRT
AIR T INCIndustrials$73M
0.01%
253NSTS
NSTS BANCORP INCFinancial Services$73M
0.01%
254HFBL
HOME FEDERAL BANCORP INC OF LOUISIANAFinancial Services$70M
0.01%
255CLST
CATALYST BANCORP INCFinancial Services$70M
0.01%
256LONA
LEONABIO INCHealthcare$68M
0.01%
257BGSF
BGSF INCIndustrials$65M
0.01%
258IMA
IMAGENEBIO INCHealthcare$61M
0.01%
259LNZA
LANZATECH GLOBAL INCIndustrials$56M
0.01%
260STEM
STEM INCTechnology$56M
0.01%
261APT
ALPHA PRO TECH LTDBasic Materials$53M
0.01%
262MCRB
SERES THERAPEUTICS INCHealthcare$52M
0.01%

Full long-leg book as of July 2026 · cap-weighted · total market cap $1.01T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

11 sectors
Technology
28.6%
Healthcare
22.1%
Real Estate
15.0%
Financial Services
10.3%
Utilities
7.7%
Basic Materials
7.0%
Industrials
2.5%
Energy
2.4%
Consumer Cyclical
2.4%
Communication Services
1.8%
Consumer Defensive
0.3%

Portfolio Style

Size × value map of the long-leg book

262 classified
Value
Blend
Growth
Large
Mid
Small
7%6
29%18
35%12
8%37
8%36
5%22
2%74
1%28
<1%11

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 85% toward Large, 62% toward Growth. +3% unclassified (18 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt85% → Large
SmallLarge
Value ↔ growth tilt62% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 262 names now. The faded start covers early months with a much thinner universe. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
3
Failed
2
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    25.6%
    Margin
    -0.6%

    Close to the line. The engine flags this verdict as one a routine data rebuild could flip. Read it as borderline rather than settled — the margin beside it is the whole story.

  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

1 verdict(s) sit within 1.0pp of their limit and can be flipped by a routine data rebuild; do not headline them, and always show the margin.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 262 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.3 (95% CI 1.1-1.4)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
12.6%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.31x
within
parametric
1.26x
within
cornish fisher
1.32x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2012
Before publication (pre-2012)
0.79
Sharpe · 11.9% p.a.
January 1999December 2012 · 168 mo
Since publication
0.23
Sharpe · 2.8% p.a.
January 2013July 2026 · 163 mo
Change in Sharpe−0.56Sharpe weakened since publication77% of the prior annual return given up

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
81%
21 of 26 3-year windows made money
Worst window
-0.43
Sharpe, January 2023 – December 2025
January 1999July 2026
Median Sharpe
0.48
Dispersion
0.55
Best window
1.94

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.16.0%15.6%
3 yearsp.a.18.7%-3.2%
5 yearsp.a.10.2%1.2%
10 yearsp.a.13.6%1.2%
Since inceptionp.a.10.5%6.7%
Calendar years
YearLong legLong-short
20267 mo10.5%15.2%
20258.6%-31.7%
202429.4%11.3%
202318.4%0.8%
2022-11.2%15.9%
202113.3%0.0%
202036.0%9.7%
201924.2%-3.7%
2018-7.5%8.7%
201711.4%-9.4%
201621.6%10.7%
2015-5.1%2.0%
20149.7%-0.3%
201349.0%10.0%
201224.3%17.5%
2011-9.2%-7.3%
201010.6%0.1%
200932.1%1.3%
2008-39.6%30.8%
2007-21.5%-22.2%
200628.1%11.7%
200517.4%13.0%
200410.8%0.3%
200346.5%5.0%
2002-23.3%10.1%
20014.7%54.4%
200031.3%102.0%
199927.0%-12.2%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FINV
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2020-05-11 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$1.01T

Methodology

The Foundry Investment Discipline Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Investment Discipline signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.